XSTO
ZZ B
Market cap542mUSD
Jul 09, Last price
133.90SEK
1D
0.15%
1Q
-11.44%
Jan 2017
1,074.56%
IPO
2,008.66%
Name
Zinzino AB
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating as a direct sales enterprise, Zinzino AB (publ) markets and distributes a comprehensive selection of nutritional supplements, coffee products, coffee machines, and associated accessories. The company's diverse offerings encompass health-focused supplements for equilibrium, immune support, weight control, and dermatological care. Furthermore, it supplies a range of espresso apparatus, various coffees, specialty teas, and other related accoutrements. Zinzino maintains a widespread international footprint, serving markets in numerous countries including Sweden, Norway, Denmark, Finland, Iceland, Estonia, Lithuania, Latvia, Germany, Austria, Switzerland, the Netherlands, Poland, Hungary, Romania, Spain, Cyprus, France, Greece, Italy, the United Kingdom, Czech Republic, Slovakia, the United States, Canada, Singapore, Malaysia, Taiwan, Thailand, Hong Kong, Australia, South Africa, and India. Established in 2005, Zinzino AB (publ) is headquartered in Gothenburg, Sweden, with additional operational bases situated in Finland, Latvia, Norway, the USA, Australia, Hong Kong, Malaysia, and India.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||